lisocabtagene maraleucel,ibrutinib,venetoclax
Bms,Roche,Abbvie,janssen
['cll 004', 'venetoclax', 'liso-cel', 'transcend cll 004', 'transcend,(-nhl-001),(-nhl 001),(-nhl001),(-nhl-006),(-nhl 006),(-nhl006),(-pilot-017006),(-pilot017006),(-pilot 017006)', 'cll']
first anticd19 cart liso-cel results in r/r cll (transcend cll 004), presented by dr tanya siddiqi cr/cri in 18% in pts with r/r cll
after btki/venetoclax failure! high umrd rates in both blood (63%) and marrow (59%) #17icml 
MD at @USAL | Internal Med student at @HematoCAUSA | #cytopath #cytometry and #lymphoma at Hospital Ramón y Cajal @HematoRYC | PhD student at @UAHes